Universität zu Köln

2018

Mathew, Nimitha R., Baumgartner, Francis ORCID: 0000-0003-0768-1956, Braun, Lukas, O'Sullivan, David, Thomas, Simone ORCID: 0000-0001-6308-3649, Waterhouse, Miguel, Mueller, Tony A., Hanke, Kathrin, Taromi, Sanaz, Apostolova, Petya ORCID: 0000-0002-3856-5109, Illert, Anna L., Melchinger, Wolfgang, Duquesne, Sandra, Schmitt-Graeff, Annette, Osswald, Lena, Yan, Kai-Li, Weber, Arnim, Tugues, Sonia, Spath, Sabine ORCID: 0000-0002-2689-1951, Pfeifer, Dietmar, Follo, Marie, Claus, Rainer ORCID: 0000-0003-2617-8766, Luebbert, Michael, Rummelt, Christoph ORCID: 0000-0002-6471-7030, Bertz, Hartmut, Waesch, Ralph, Haag, Johanna, Schmidts, Andrea ORCID: 0000-0001-7035-1584, Schultheiss, Michael, Bettinger, Dominik, Thimme, Robert, Ullrich, Evelyn ORCID: 0000-0001-8530-1192, Tanriver, Yakup ORCID: 0000-0002-4806-2548, Vuong, Giang Lam, Arnold, Renate, Hemmati, Philipp, Wolf, Dominik, Ditschkowski, Markus, Jilg, Cordula, Wilhelm, Konrad, Leiber, Christian, Gerull, Sabine, Halter, Joerg, Lengerke, Claudia ORCID: 0000-0001-5442-2805, Pabst, Thomas, Schroeder, Thomas, Kobbe, Guido, Roesler, Wolf, Doostkam, Soroush, Meckel, Stephan ORCID: 0000-0001-6468-4526, Stabla, Kathleen, Metzelder, Stephan K., Halbach, Sebastian ORCID: 0000-0002-6827-8178, Brummer, Tilman ORCID: 0000-0003-4387-7905, Hu, Zehan, Dengjel, Joern ORCID: 0000-0002-9453-4614, Hackanson, Bjoern, Schmid, Christoph, Holtick, Udo, Scheid, Christof, Spyridonidis, Alexandros, Stoelzel, Friedrich, Ordemann, Rainer, Mueller, Lutz P., Sicre-de-Fontbrune, Flore, Ihorst, Gabriele, Kuball, Juergen, Ehlert, Jan E., Feger, Daniel, Wagner, Eva-Maria, Cahn, Jean-Yves, Schnell, Jacqueline, Kuchenbauer, Florian, Bunjes, Donald, Chakraverty, Ronjon ORCID: 0000-0003-2301-2664, Richardson, Simon ORCID: 0000-0003-4343-4784, Gill, Saar, Kroeger, Nicolaus, Ayuk, Francis, Vago, Luca ORCID: 0000-0003-4247-3175, Ciceri, Fabio, Mueller, Antonia M., Kondo, Takeshi ORCID: 0000-0001-7455-5824, Teshima, Takanori, Klaeger, Susan ORCID: 0000-0002-0074-5163, Kuster, Bernhard, Kim, Dennis (Dong Hwan), Weisdorf, Daniel, van der Velden, Walter, Doerfel, Daniela, Bethge, Wolfgang, Hilgendorf, Inken ORCID: 0000-0003-2038-9730, Hochhaus, Andreas, Andrieux, Geoffroy, Boerries, Melanie, Busch, Hauke ORCID: 0000-0003-4763-4521, Magenau, John, Reddy, Pavan, Labopin, Myriam, Antin, Joseph H., Henden, Andrea S., Hill, Geoffrey R., Kennedy, Glen A., Bar, Merav, Sarma, Anita, McLornan, Donal, Mufti, Ghulam, Oran, Betul, Rezvani, Katayoun, Shah, Omid, Negrin, Robert S., Nagler, Arnon, Prinz, Marco, Burchert, Andreas, Neubauer, Andreas, Beelen, Dietrich, Mackensen, Andreas, von Bubnoff, Nikolas, Herr, Wolfgang, Becher, Burkhard, Socie, Gerard, Caligiuri, Michael A., Ruggiero, Eliana ORCID: 0000-0002-2954-8278, Bonini, Chiara, Haecker, Georg, Duyster, Justus, Finke, Juergen, Pearce, Erika, Blazar, Bruce R. and Zeiser, Robert (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat. Med., 24 (3). S. 282 - 295. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1546-170X

Wolf, Christine, Garding, Angela, Filarsky, Katharina, Bahlo, Jasmin, Robrecht, Sandra, Becker, Natalia, Zucknick, Manuela ORCID: 0000-0003-1317-7422, Rouhi, Arefeh, Weigel, Anja, Claus, Rainer ORCID: 0000-0003-2617-8766, Weichenhan, Dieter, Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael, Kuchenbauer, Florian, Plass, Christoph, Doehner, Hartmut, Stilgenbauer, Stephan, Lichter, Peter and Mertens, Daniel ORCID: 0000-0003-0227-7188 (2018). NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int. J. Cancer, 142 (2). S. 322 - 334. HOBOKEN: WILEY. ISSN 1097-0215

2012

Bloehdorn, Johannes, Sill, Martin, Buehler, Andreas, Mack, Silja, Winter, Doris, Bullinger, Lars, Rouhi, Arefeh, Kuchenbauer, Florian, Mertens, Daniel, Benner, Axel, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2012). Microrna Expression in Fludarabine-Refractory CLL Implicates Independent Mechanisms of Resistance and Is Associated with Response and Progression Free Survival After Alemtuzumab Treatment: Results From the CLL2H Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971